Figure 1:

Infographic shows approximate diagnostic yields of systematic biopsy in biopsy-naive men on the MRI pathway. The MRI pathway consists of no biopsy in men with Prostate Imaging and Reporting Data System (PI-RADS) category 1 or 2 findings and MRI-targeted biopsy in men with PI-RADS category 3–5 findings, without additional clinical factor input. Data are for guidance only and are based on a combination of the MRI pathway and systematic biopsy as the reference standards. Data do not total 100% because of rounding and aggregation of different data sources reported by Drost et al (10). Data in parentheses are 95% confidence intervals for the mean values. ISUP = International Society of Urological Pathology. This graphic was prepared with data kindly provided by Ivo Schoots, MD, PhD (Erasmus University Medical Center, Rotterdam, the Netherlands).